Global health service company Cigna is on a mission: to get HopeLab’s cancer-fighting game app Re-Mission 2: Nanobot’s Revenge onto the phones and tablets of every young cancer patient in the world. The free app is available for Android and iOS (Apple) mobile devices.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/62267-cigna-hopelab-re-mission-2-mobile-app
Today’s superheroes don’t drive a Batmobile or fly through the air faster than the speed of light. Their capes are white lab coats and their superpower is the ability to cure. They are men and women researching cures for childhood cancer – the leading cause of death by disease in children under the age of 15 in the U.S.1- which is vastly underfunded.2
Starting today, Northwestern Mutual is giving consumers the chance to honor childhood cancer researchers and kids who are fighting cancer, by raising research funds through a new Facebook campaign, Heroes for a Cure. The Northwestern Mutual campaign aims to raise $50,000 – equal to 1,000 hours of research – in September, which is National Childhood Cancer Month.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59532-northwestern-mutual-launches-heroes-for-cure-campaign-fight-child-cancer
The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign is proud to announce its 2013 global Campaign for Breast Cancer Awareness Month and beyond. The 2013 theme, “Let’s Defeat Breast Cancer. We’re Stronger Together.”, is a call-to-action that will serve to shift public focus from awareness to increased action, advancing us further towards eradicating breast cancer from our lives. To date, The BCA Campaign has raised more than $48 million to support global research, education and medical services. This year’s BCA Campaign is committed to raising $5 million to support breast cancer research, education and medical services worldwide. Action doesn’t happen alone. When we join together…We’re Stronger Together.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63597-estee-lauder-elizabeth-hurley-breast-cancer-aware-campaign-aware-action
With September marking the kickoff of the pro-football season and National Prostate Cancer Awareness Month, the Urology Care Foundation and the National Football League (NFL) teamed up to release a new Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to join the Know Your Stats® campaign.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63352-nfl-and-urology-care-foundation-national-prostate-cancer-awareness-month
Lynn Napoli Marynowski and her younger brother Frank Napoli are as close as a big sister and little brother can be. They are an extension of their tight-knit family. From being raised together (along with a brother), to working together—Lynn has worked at the Chicago Mercantile Exchange for 25 years and Frank 17 years—and, to this day, still living nearby each other, their parents and brother in Chicago and surrounding suburbs, Lynn and Frank share a close sibling connection. So, when Lynn was struck with the diagnosis of Stage 3 breast cancer back in June 2012, that road—no matter how long—would also be theirs to travel together.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63625-northwestern-memorial-hospital-lynn-sage-cancer-research-foundation
More than 80,000 healthcare workers and their communities from across the country and around the world joined together in the Medline Pink Glove Dance for breast cancer online video competition. After a hard-fought dance battle, the online votes are in and Medline is pleased to name Geisinger Health System, Danville, Pa., as the winner. As a result, $25,000 will be donated to their charity of choice, the American Cancer Society, providing free transportation for treatment to central Pennsylvania breast cancer patients in need. Additionally, Medline and participating hospitals will donate another $1 million to the National Breast Cancer Foundation and various local breast cancer charities nationwide. More than $2.2 million has been donated through the campaign and Medline Foundation since 2005.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64450-medline-pink-glove-dance-video-competition-winners-breast-cancer-education
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
Eagle Rare Kentucky Straight Bourbon Whiskey has named Angie Goodwin of Calhoun, Ky., as the winner of the Grand Prize 2014 Rare Life Award. Eagle Rare will donate $40,000 to Goodwin’s charity, Thumbs Up for Lane Goodwin Childhood Cancer Foundation, and host an awards ceremony in Henderson on March 7. Angie and her late son Lane started the foundation to support childhood cancer research through funding and advocacy and to assist families battling childhood cancer by providing education, financial assistance and a volunteer network.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64624-eagle-rare-bourbon-angie-goodwin-grand-prize-2014-rare-life-award
Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month
‘Tackling hepatitis C: Moving towards an integrated policy approach’, a report published by The Economist Intelligence Unit (EIU) today reveals that many countries around the world have been slow to respond with national policies on hepatitis C despite recent government pledges to fight the disease. The hepatitis C virus remains the leading cause of liver cancer, liver disease and liver transplantation placing a huge burden on patients' lives and healthcare systems.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/71400562-janssen-new-reports-hepatitis-c
St. Jude Children’s Research Hospital, www.stjude.org, announced today the appointment of James R. Downing, M.D., as its new CEO, effective July 15, 2014. Downing most recently has served as the Deputy Director, Executive Vice President and Scientific Director of the hospital, which is leading the way the world understands, treats and defeats pediatric cancer and other catastrophic diseases. Downing’s primary focus immediately upon assuming the CEO office will be to oversee a new era of clinical, research and infrastructure expansion throughout the St. Jude global network. He succeeds Dr. William E. Evans, who is retiring from the position after 10 years and returning full time to his long-standing pharmacogenomics research program at St. Jude.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7256651-st-jude-children-s-research-hospital-new-era-of-expansion-and-growth/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
